Title : Genetic polymorphisms of CYP2C19 2 and ABCB1 C3435T affect the pharmacokinetic and pharmacodynamic responses to clopidogrel in 401 patients with acute coronary syndrome.

Pub. Date : 2015 Mar 10

PMID : 25542807






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Genetic polymorphisms of CYP2C19 2 and ABCB1 C3435T affect the pharmacokinetic and pharmacodynamic responses to clopidogrel in 401 patients with acute coronary syndrome. Clopidogrel ATP binding cassette subfamily B member 1 Homo sapiens
2 Notably, the carriers of ABCB1 C3435T were associated with lower levels of plasma clopidogrel and its active (clopi-H4) and inactive (CLPM) metabolites (all P<0.05 vs. non-carriers) which also correlated with subsequently decreased platelet inhibition (P<0.05 vs. non-carriers). Clopidogrel ATP binding cassette subfamily B member 1 Homo sapiens
3 Meanwhile, ABCB1 C3435T plays an important role in intestinal absorption of clopidogrel which further affects the exposure to the active metabolite of clopidogrel and platelet aggregation. Clopidogrel ATP binding cassette subfamily B member 1 Homo sapiens
4 Meanwhile, ABCB1 C3435T plays an important role in intestinal absorption of clopidogrel which further affects the exposure to the active metabolite of clopidogrel and platelet aggregation. Clopidogrel ATP binding cassette subfamily B member 1 Homo sapiens